<DOC>
	<DOCNO>NCT02774265</DOCNO>
	<brief_summary>The purpose study perform pragmatic randomize control trial compare use low molecular weight heparin ( LMWH , lovenox , enoxaparin ) versus acetylsalicylic acid ( ASA ) venous thromboembolism ( VTE ) prophylaxis patient high-risk low extremity fracture .</brief_summary>
	<brief_title>A Different Approach Preventing Thrombosis</brief_title>
	<detailed_description>Purpose : To perform pragmatic randomize controlled trial use low molecular weight heparin ( LMWH , enoxaparin , lovenox ) versus Aspirin ( ASA ) VTE prophylaxis patient high-risk extremity fracture . Specific Aims : 1 . To compare bleed complication outcomes associate LMWH versus ASA patient receive VTE prophylaxis follow high-risk low extremity fracture . 2 . To compare incidence clinically important VTE event associate LMWH versus ASA VTE prophylaxis patient receive VTE prophylaxis follow high-risk low extremity fracture . 3 . To compare 6-month treatment cost associate VTE prophylaxis use either LMWH ASA high-risk low extremity fracture patient Hypothesis : 1 . Among patient high risk lower extremity fracture receive VTE prophylaxis , rate bleeding complication low patient receive ASA compare receive LMWH . 2 . Among patient high risk lower extremity fracture receive VTE prophylaxis , rate VTE patient receive ASA great receive LMWH . 3 . Among patient high risk lower extremity fracture receive VTE prophylaxis , 6-month treatment cost low patient receive ASA compare receive LMWH . Methods/Outcomes : A randomized control trial conduct ass use LMWH versus ASA VTE prophylaxis patient high-risk extremity fracture . The aim-specific outcome collect follow : 1 . A composite following major bleed related complication : 1 . Fatal bleed critical organ ( retroperitoneal , intracranial , intraocular , intraspinal ) 2 . Clinically overt bleed &gt; 2g/dL drop Hb require &gt; 2U transfusion 3 . Wound drainage hematoma require reoperation 4 . Diagnosis deep surgical site infection 2 . VTE Events define composite symptomatic proximal DVT ( femoral popliteal vessel ) , PE ( central , segmental subsegmental ) . All VTE event confirm use multiplanar CT scan formal venous duplex exam . 3 . Cost VTE prophylaxis treatment , VTE event bleed related complication . Data Collection : Patients meet inclusion/exclusion criterion prospectively randomize one two treatment arm . Block randomization variable block size use . Patients receive VTE prophylaxis allocate , follow 6month period VTE event bleed complication . Outcome data prospectively collect 2,4,6,12 24 week post injury , blind analysis interpretation result perform 50 % 100 % recruitment . Data Analysis : All data report mean standard deviation continuous variable proportion percentage categorical data . Kaplan-Meier survival Cox proportional hazard analysis complete time VTE bleed complication outcome . Sub-group analysis include Injury Severity Score fracture location . An independent Data Safety Monitoring Committee complete interim analysis 50 % recruitment . A cost analysis conduct use 6month lifetime time horizon societal perspective . Component cost consist : VTE prophylaxis cost , unscheduled follow-up , emergency room visit , hospital admission unscheduled repeat surgical intervention VTE bleeding complication . Study Treatment Arms : 1 . VTE prophylaxis Enoxaparin 30mg SC BID 2 . VTE prophylaxis ASA 81mg PO BID</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>All patient treat level1 trauma center one follow injury : Pelvis fracture ( operative nonoperative ) , Acetabulum fracture ( operative nonoperative ) , operative extremity fracture ( proximal tarsals/carpals ) Age great equal 18 year old Patients receive preexist confound prophylaxis therapeutic anticoagulation ( include antiplatelet agent ) prior admission receive great one dose LMWH since injury Patients preexist coagulopathy Patients previous history VTE within last 6 month Patients pregnant Injury great 24hrs prior arrival treat hospital Patients CNS spinal cord injury preclude anticoagulation Patients active bleed precluding use anticoagulation Impaired creatinine clearance &lt; 30ml/min time randomization History Heparin Induced Thrombocytopenia ASA NSAID allergy Prisoners Nonenglish speaking patient Patients indication therapeutic anticoagulation Patients deem inappropriate inclusion study treat physician . Reason must document Patients would normally receive VTE prophylaxis injury</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Fracture</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>